Statement Of Investor Complaints For The Quarter Ended June 30, 2017
Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, we submit here under the statement of Investor Complaints for the quarter ended June 30, 2017. Unichem gets EIR from USFDA for Goa plant
Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company's plant at Goa. The company's formulations manufacturing facility at Goa has... Press Release
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for the Company's manufacturing facility at Goa. AGM on July 22, 2017
Unichem Laboratories Ltd has informed BSE that the 54th Annual General Meeting (AGM) of the Company will be held on July 22, 2017. Updates
In continuance to our letter dated May 30, 2017 intimating the outcome of the Board meeting held on May 30, 2017, please find enclosed the Notice of the 54th Annual General Meeting (AGM) of the Company to be held on Saturday, July 22, 2017 at the Hall of Culture, Nehru Centre, Dr. Annie Besant Road, Worli, Mumbai 400 018. The Annual Report for the year ended March 31, 2017 along with the Notice is dispatched to the Shareholders of the Company... Unichem Laboratories aims $ 100 mn revenue from US
For this, the company will focus on differentiated complex generics, which are difficult to produce Updates
Investor Presentation on the audited financial results for the quarter and year ended March 31, 2017 Unichem lines up 350-cr capex
Drug firm Unichem Laboratories has lined up a capex of around 350 crore for the next two years as it plans to strengthen R&D activity and expand operations in the US market. The company,... Transcript On Audited Financial Results For Q4 & FY17
Transcript on audited financial results for the quarter and year ended March 31, 2017. Unichem gets EIR for Ghaziabad formulation unit
Unichem Laboratories has received an establishment inspection report from the US health regulator for its formulation manufacturing facility in Ghaziabad. The company's formulations...